<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">RSX</journal-id>
<journal-id journal-id-type="hwp">sprsx</journal-id>
<journal-id journal-id-type="nlm-ta">Reprod Sci</journal-id>
<journal-title>Reproductive Sciences</journal-title>
<issn pub-type="ppub">1933-7191</issn>
<issn pub-type="epub">1933-7205</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1933719112451146</article-id>
<article-id pub-id-type="publisher-id">10.1177_1933719112451146</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Epigenetic Disorder May Cause Downregulation of HOXA10 in the Eutopic Endometrium of Fertile Women With Endometriosis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Lu</surname>
<given-names>Hong</given-names>
</name>
<degrees>MS</degrees>
<xref ref-type="aff" rid="aff1-1933719112451146">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Xiaoqing</given-names>
</name>
<degrees>MS</degrees>
<xref ref-type="aff" rid="aff1-1933719112451146">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zhang</surname>
<given-names>Yuquan</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff1-1933719112451146">1</xref>
<xref ref-type="corresp" rid="corresp1-1933719112451146"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lu</surname>
<given-names>Rong</given-names>
</name>
<degrees>MS</degrees>
<xref ref-type="aff" rid="aff2-1933719112451146">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Xiumei</given-names>
</name>
<degrees>BS</degrees>
<xref ref-type="aff" rid="aff3-1933719112451146">3</xref>
</contrib>
</contrib-group>
<aff id="aff1-1933719112451146">
<label>1</label>Department of Obstetrics and Gynecology, The Affiliated Hospital of Nantong University, Nantong, Jiangsu, China</aff>
<aff id="aff2-1933719112451146">
<label>2</label>Department of Obstetrics and Gynecology, The Maternal and Child Health Hospital of Nantong University, Nantong, Jiangsu, China</aff>
<aff id="aff3-1933719112451146">
<label>3</label>Department of Obstetrics and Gynecology, The People’s Hospital of Haian, Haian, Jiangsu, Haian, China</aff>
<aff id="aff3a-1933719112451146">
<label>*</label>The authors contributed equally to the study</aff>
<author-notes>
<corresp id="corresp1-1933719112451146">Yuquan Zhang, Department of Obstetrics and Gynecology, Affiliated Hospital of Nantong University, Jiangsu, Nantong, 226001 China Email: <email>jsnt_zhangyuquan@yahoo.com.cn</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>1</month>
<year>2013</year>
</pub-date>
<volume>20</volume>
<issue>1</issue>
<fpage>78</fpage>
<lpage>84</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">Society for Gynecologic Investigation</copyright-holder>
</permissions>
<abstract>
<p>HOXA10 is an important gene for endometrial receptivity and plays a regulatory role in the adult female reproductive tract. It is regulated by epigenetic modulation in the CpG clusters of promoter in some cases. The aim of this study was to investigate HOXA10 expression and the epigenetic regulation in the eutopic endometrium of fertile women with endometriosis by quantitative real-time polymerase chain reaction (RT-PCR) and Western blot. The effect of 5-azacytidine (5-ac), a demethylation agent on HOXA10 expression was determined on endometrium stromal cells (ESCs) from these women with endometriosis. Results revealed that in normal endometrium (NE), HOXA10 messenger RNA (mRNA) and protein expression at the secretory phase were significantly higher than that at the proliferative phase. The HOXA10 mRNA and protein expression in the eutopic endometrium of endometriosis were significantly lower than in NE. The HOXA10 mRNA and protein levels in cultured stromal cells from endometriosis in vitro were significantly increased in a 5-ac treatment group compared with a nontreatment group. Our results indicated that the level of HOXA10 decrease in the eutopic endometrium of patients with endometriosis. Upregulation of HOXA10 in ESCs after treatment with 5-ac suggests that HOXA10 expression is controlled by methylation of the promoter. An epigenetic aberration is likely the main cause of endometriosis.</p>
</abstract>
<kwd-group>
<kwd>HOXA10</kwd>
<kwd>endometrium</kwd>
<kwd>endometriosis</kwd>
<kwd>DNA methylation</kwd>
<kwd>5-azacytidine</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-1933719112451146">
<title>Introduction</title>
<p>Endometriosis is one of the most common chronic and benign gynecological disorders. It affects 5% to 10% of women at reproductive age.<sup><xref ref-type="bibr" rid="bibr1-1933719112451146">1</xref></sup> Endometriosis can decrease the receptivity of endometrium, hinder the development of oocyte and embryo, and impair the function of uterine tubes, and increasing the chances of infertility.<sup><xref ref-type="bibr" rid="bibr2-1933719112451146">2</xref></sup> It is also linked with lower pregnancy rates in women undergoing in vitro fertilization.<sup><xref ref-type="bibr" rid="bibr3-1933719112451146">3</xref></sup> However, so far, the specific mechanisms that account for the lower pregnancy rate related to endometriosis are poorly understood and the most common treatment for infertility caused by endometriosis is surgical removal of endometriotic tissue and/or assisted reproductive technology. Many studies on endometriosis-associated infertility focus on the altered peritoneal environment, immune function, poor oocyte quality, reduced endometrial receptivity, and altered gene expression. Reduced endometrial receptivity is one of the most important causes of endometriosis-associated infertility. Endometrial receptivity is a multiple event. It involves changes in the expression of genes related to the attachment of trophectoderm to the uterine luminal epithelium and superficial glandular epithelium, modification of the phenotype of uterine stromal cells, silencing of PGR and ESR1 genes, suppression of genes for immune recognition, alterations in membrane permeability to enhance conceptus–maternal exchange of factors, increased endometrium revascularization and activation of genes for nutrient transport into the uterine lumen, and enhanced signaling for pregnancy recognition.<sup><xref ref-type="bibr" rid="bibr4-1933719112451146">4</xref></sup></p>
<p>The HOXA10 is an Abd B-like Hox gene and a member of the homeobox family. It is expressed in the developing genitourinary system in vertebrates and has a regulatory role in the adult female reproductive tract.<sup><xref ref-type="bibr" rid="bibr5-1933719112451146">5</xref></sup> HOXA10 is also an important gene for endometrial receptivity.<sup><xref ref-type="bibr" rid="bibr6-1933719112451146">6</xref>,<xref ref-type="bibr" rid="bibr7-1933719112451146">7</xref></sup> Null mutations of HOXA10 in mice cause female infertility, primarily due to defective implantation and decidualization.<sup><xref ref-type="bibr" rid="bibr8-1933719112451146">8</xref></sup> HOXA10 acts as a transcription factor, regulating expression of genes such as cyclin-dependent kinase inhibitor 1A,<sup><xref ref-type="bibr" rid="bibr9-1933719112451146">9</xref></sup> Wnt pathway components,<sup><xref ref-type="bibr" rid="bibr10-1933719112451146">10</xref></sup> integrin β3,<sup><xref ref-type="bibr" rid="bibr11-1933719112451146">11</xref></sup> FK506-binding protein 4,<sup><xref ref-type="bibr" rid="bibr12-1933719112451146">12</xref></sup> insulin-like growth factor-binding protein 1,<sup><xref ref-type="bibr" rid="bibr13-1933719112451146">13</xref></sup> and empty spiracles homolog 2.<sup><xref ref-type="bibr" rid="bibr14-1933719112451146">14</xref></sup> These genes are important in endometrial decidualization, receptivity establishment, embryo localization, and vasopermeability. The HOXA10 expression in the eutopic endometrium of infertile patients with endometriosis is significantly lower than in normal endometrium (NE).<sup><xref ref-type="bibr" rid="bibr15-1933719112451146">15</xref>,<xref ref-type="bibr" rid="bibr16-1933719112451146">16</xref></sup> Recent studies demonstrate that epigenetic alteration might be responsible for this aberration by elevating DNA methylation in the CpG clusters of a HOXA10 gene promoter.<sup><xref ref-type="bibr" rid="bibr13-1933719112451146">13</xref>,<xref ref-type="bibr" rid="bibr17-1933719112451146">17</xref></sup> However, whether the epigenetic disorder is involved in the HOXA10 expression in eutopic endometrium of patients with endometriosis is unclear.</p>
<p>5-Azacytidine (5-ac) is a pyrimidine nucleoside analog discovered more than 40 years ago.<sup><xref ref-type="bibr" rid="bibr18-1933719112451146">18</xref></sup> It inhibits phenol-<italic>o</italic>-methyl shift enzyme activity of DNA methylation and can activate methylation deactivation of genes. Currently, it is widely used in gene methylation experiments including studies on patients with endometriosis.<sup><xref ref-type="bibr" rid="bibr19-1933719112451146">19</xref>,<xref ref-type="bibr" rid="bibr20-1933719112451146">20</xref></sup> However, no report has addressed HOXA10 expression in the endometriotic eutopic endometrium treated with 5-ac.</p>
<p>This study investigated the expression of HOXA10 messenger RNA (mRNA) and proteins in the eutopic endometrium of fertile patients with endometriosis and the effect of 5-azacytidine (5-ac) on HOXA10 expression in eutopic endometrial stromal cells cultured in vitro.</p>
</sec>
<sec id="section2-1933719112451146" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="section3-1933719112451146">
<title>Ethics</title>
<p>This study was approved by the institutional review board of the Affiliated Hospital of Nantong University. Written informed consent for the use of tissue was obtained from each woman involved in the study.</p>
</sec>
<sec id="section4-1933719112451146">
<title>Samples</title>
<p>Normal endometrial tissue was collected from 12 fertile women without endometriosis, including 6 samples collected during the mid-secretory phase (normal endometrial in secretory phase, NES; days 20-22) and 6 samples was collected during the mid-proliferative phase (normal endometrial in proliferative phase, NEP; days 9-11) of the menstrual cycle. Eutopic endometrium was collected from 12 fertile patients including 6 samples from the mid-secretory phase (endometriotic eutopic endometrium in the secretory phase, EEES; days 20-22) and 6 from the mid-proliferative phase (endometriotic eutopic endometrium in the proliferative phase, EEEP; days 9-11) of the menstrual cycle.</p>
<p>Samples were obtained immediately after surgery, placed in liquid nitrogen and stored at −80°C for RNA and protein extraction. At the same time, endometrial stromal cells (ESCs) were established as primary cultures from the 6 cases of EEES. Some EEES samples were collected in phosphate-buffered saline (PBS) and taken to the tissue culture laboratory for ESC isolation. The mean age of the women was not significantly different in any group. No patients received any preoperative hormonal therapy. All samples were processed for histological examination to confirm the menstrual cycle phase.</p>
</sec>
<sec id="section5-1933719112451146">
<title>Primary Endometrial Stromal Cell Culture</title>
<p>The ESCs from 6 women at EEES were isolated using a previously reported protocol with minor modifications.<sup><xref ref-type="bibr" rid="bibr21-1933719112451146">21</xref></sup> Briefly, tissues were rinsed in PBS, minced, and digested with 4 mg/mL collagenase (Sigma, St Louis, Missouri) and DNase (Sigma) at 37°C for 1 hour. The ESCs were separated from epithelial cells by draining through 100 and 40 µm sieves, then suspended in Dulbecco modified Eagle medium (DMEM)/F12 1:1 containing 10% fetal bovine serum (both from Invitrogen, Grand Island, New York) and cultured in a humidified atmosphere with 5% CO<sub>2</sub> in air at 37°C. The purity of ESC was determined by morphology and immunofluorescence staining using antibodies against vimentin (1:100; Abcam 8979, Hongkong Ltd.) and cytokeratin (1:100; Abcam 9221, Hongkong Ltd.).</p>
</sec>
<sec id="section6-1933719112451146">
<title>Western Blot Analysis</title>
<p>Tissues were washed in ice-cold PBS and suspended in a protein extraction reagent (Pierce, Rockford, Illinois). Lysates were centrifuged at 15 700<italic>g</italic> for 10 minutes. Equal amounts of proteins (15 µg) were resolved in 10% arc-bis gels, transferred to polyvinylidene difluoride membranes, and incubated with anti-human HOXA10 antibody (Santa Cruz Biotechnology, Santa Cruz, California; 1:500 dilution). Anti-β-actin antibody served as a loading control. Detection was performed using a SuperSignal West Femto, Maximum Sensitivity Substrate System (Pierce). Protein band intensity was quantified using Quantity One Analysis software (Bio-Rad Laboratories, Los Angeles, California).</p>
</sec>
<sec id="section7-1933719112451146">
<title>RNA Extraction and Quantitative Analysis by Real-Time-PCR</title>
<p>Total RNA was isolated from tissues and ESCs using RISOTM RNA reagent (Biomics Biotechnologies Co. Ltd. Jiangsu, China) following the manufacturer’s instructions. RNA was reverse-transcribed and amplified using an EzOmics One-Step qualitative polymerase chain reaction (qPCR) kit (Biomics) in a Bio-Rad iQ5 sequence system (BioRad, USA). The HOXA10 expression was detected with glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as an internal control. Briefly, 0.4 µg of total RNA was amplified in a 25 µL reaction with 400 nmol/L of primers (HOXA10-forward: 5′-ACAAGCACACCACAATTCTCC-3′ and HOXA10-reverse: 5′-ATCCAAACAATGTCTCCCTTCTC-3′; GAPDH-forward:5′-GAAGGTGAAGGTCGGAGTC-3′ and GAPDH-reverse: 5′-GAAGATGGTGATGGGATTTC-3′). The thermocyler program was 3 minutes at 95°C; 45 amplification cycles (10 seconds at 94°C, 30 seconds at 58°C, and 30 seconds at 78°C with fluorescent detection); 1 minute at 95°C; 1 minute at 55°C; and 30 second at 0.5°C increments from 55 to 95°C to determine the melting curve. Relative quantification of mRNA was performed using the comparative threshold (CT) cycles method. Comparative threshold was used to determine the mRNA level normalized to the average mRNA level in ESCs. The mRNA levels were expressed as an <italic>n</italic>-fold difference. For each sample, the gene CT value was normalized using the formula: CT = CT HOXA10 − CT GAPDH. To determine the relative expression levels, the following formula was used: CT = CT sample − CT calibrator. This value was used to plot the gene expression employing the formula 2<sup>−CT</sup>.</p>
</sec>
<sec id="section8-1933719112451146">
<title>5-Azacytidine Treatments</title>
<p>The 6 cases of secretory phase ESCs (EEES) were divided into 2 groups (treated and nontreated). To determine the best concentrations for 5-ac, all ESCs were cultured in serum-free DMEM/F12 medium for 24 hours. Treated ESCs were treated with 0.5, 1, 2, 4, 6, or 8 μg/mL of the DNA methyltransferase (DNMT) inhibitor, 5-ac (Sigma) for 5 days. The duration of drug interaction was based on previous reports.<sup><xref ref-type="bibr" rid="bibr19-1933719112451146">19</xref></sup> Medium was changed daily.</p>
<p>Cells were counted with the trypan blue dye exclusion method. Cells were trypsinized and washed with PBS. An aliquot (50 μL) of cell suspensions was incubated with the same volume of trypan blue and cells were counted under a light microscopy with a hemocytometer. Based on cell counts, we chose a suitable concentration of 5-ac for further experiments. The EEES samples were treated or not treated with the chosen concentration of 5-ac. After 5 days, total RNA was extracted for quantitative real time (RT)-PCR and Western blot. All experiments were conducted in triplicate and repeated 3 times.</p>
</sec>
<sec id="section9-1933719112451146">
<title>Statistical Analysis</title>
<p>Student <italic>t</italic> tests were used to compare gene expression between the 2 groups. <italic>P</italic> &lt; .05 was considered statistically significant.</p>
</sec>
</sec>
<sec id="section10-1933719112451146">
<title>Results</title>
<sec id="section11-1933719112451146">
<title>The HOXA10 Endometrium mRNA Expression at Different Menstrual Cycle Phases</title>
<p>In NE, quantitative RT-PCR showed that HOXA10 mRNA expression was significantly higher at the secretory phase (NES) than the proliferative phase (NEP; <italic>P</italic> &lt; .05). However, this was not detected in EEE samples from women with endometriosis. The EEE samples at the secretory phase (n = 6; EEES) expressed a similar level of HOXA10 mRNA transcripts as those at the proliferative phase (n = 6; EEEP) from women with endometriosis (<italic>P</italic> &gt; .05; <xref ref-type="fig" rid="fig1-1933719112451146">Figure 1</xref>).</p>
<fig id="fig1-1933719112451146" position="float">
<label>Figure 1.</label>
<caption>
<p>HOXA10 messenger RNA (mRNA) expression by real-time polymerase chain reaction (RT-PCR) in normal endometrium (NE) and endometriotic eutopic endometrium (EEE). HOXA10 mRNA expression in the NE at secretory phase (NES) was significantly higher than in the NE at proliferative phase (NEP; <italic>P</italic> &lt; .05). No significant difference was seen for HOXA10 mRNA expression at the secretory phase of the endometriotic eutopic endometrium (EEES) compared to the proliferative phase of the endometriotic eutopic endometrium (EEEP; <italic>P</italic> &gt; .05). In HOXA10 mRNA expression in normal versus endometriotic eutopic endometrium, NES expressed significantly higher transcripts than EEES (<italic>P</italic> &lt; .05), and NEP expressed higher HOXA10 mRNA than EEEP (<italic>P</italic> &lt; .05).</p>
</caption>
<graphic xlink:href="10.1177_1933719112451146-fig1.tif"/>
</fig>
</sec>
<sec id="section12-1933719112451146">
<title>The HOXA10 mRNA Expression in the Endometrium in Normal Health and Eutopic Endometrium Endometriosis</title>
<p>Quantitative RT-PCR analysis revealed that NE samples expressed significantly higher levels of HOXA10 mRNA than EEE samples, both at the secretory (<italic>P</italic> &lt; .05) and proliferative phases (<italic>P</italic> &lt; .05; <xref ref-type="fig" rid="fig1-1933719112451146">Figure 1</xref>).</p>
</sec>
<sec id="section13-1933719112451146">
<title>The HOXA10 Protein Endometrium Levels in Different Menstrual Cycle Phases</title>
<p>Western blot analysis showed that the protein level of HOXA10 at NES was significantly higher than at NEP in NE samples (<italic>P</italic> &lt; .01). In EEE samples, the protein level of HOXA10 at EEES was higher than EEEP, although this was not significant (<italic>P</italic> &gt; .05). The results are shown in <xref ref-type="fig" rid="fig2-1933719112451146">figure 2</xref>.</p>
</sec>
<sec id="section14-1933719112451146">
<title>The HOXA10 Protein Levels in Endometrium in Normal Health and Eutopic Endometrium Endometriosis</title>
<p>Western blots showed that NE samples expressed significantly higher levels of HOXA10 protein than EEE samples, not only at the NES (<italic>P</italic> &lt; .05) but at NEP (<italic>P</italic> &lt; .05; <xref ref-type="fig" rid="fig2-1933719112451146">Figure 2</xref>).</p>
<fig id="fig2-1933719112451146" position="float">
<label>Figure 2.</label>
<caption>
<p>HOXA10 protein expression by Western blot in normal endometrium (NE) and endometriotic eutopic endometrium (EEE). (A) Proteins were extracted from NE at secretory phase (NES), NE at proliferative phase (NEP), endometriotic eutopic endometrium at secretory phase (EEES) and endometriotic eutopic endometrium at proliferative phase (EEEP) and subjected to Western blot. β-Actin protein was assayed in parallel as an internal control. (B) Quantitative analysis of average HOXA10 protein level normalized by β-actin in each group. HOXA10 protein in NES was significantly higher than in NEP (<italic>P</italic> &lt; .05). No significant difference was seen for HOXA10 protein levels in EEES compared to EEEP (<italic>P</italic> = .05). However, HOXA10 protein in NES and NEP were significantly higher than in EEES (<italic>P</italic> &lt; .05) and EEEP, respectively (<italic>P</italic> &lt; .05).</p>
</caption>
<graphic xlink:href="10.1177_1933719112451146-fig2.tif"/>
</fig>
</sec>
<sec id="section15-1933719112451146">
<title>Induction of HOXA10 Expression by 5-ac in Eutopic Endometrium Endometriosis</title>
<p>The ESC primary cultures were established for 6 cases of EEES. Cell viability was determined by the trypan blue exclusion method after treatment with 0, 0.5, 1, 2, 4, 6, or 8 μg/mL of 5-ac. <xref ref-type="table" rid="table1-1933719112451146">Table 1</xref> shows that treatment with more than 4 μg/mL of 5-ac dramatically decreased the number of viable cells (<italic>P</italic> &lt; .01). In contrast, when cells were exposed to 5-ac at less than 1 μg/mL, no significant reduction was observed (<italic>P</italic> &gt; .05).<bold/> In all ESC cultures, treatment with 2 μg/mL 5-ac significantly enhanced HOXA10 expression compared with nontreated groups at both the mRNA level by quantitative RT-PCR (<xref ref-type="fig" rid="fig3-1933719112451146">Figure 3A</xref> and B; <italic>P</italic> &lt; .05), and at the protein level by Western blot (<xref ref-type="fig" rid="fig3-1933719112451146">Figure 3C</xref> and D; <italic>P</italic> &lt; .05).</p>
<fig id="fig3-1933719112451146" position="float">
<label>Figure 3.</label>
<caption>
<p>Induction of HOXA10 messenger RNA (mRNA) and protein in 6 samples of endometrium stromal cells (ESCs) of EEES by 5-azacytidine. (A) Real-time polymerase chain reaction (PCR) for HOXA10 mRNA in 6 samples of treated ESCs and in 6 samples of nontreated ESCs. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA was assayed as an internal control. (B) Quantitative analysis of pooled data showed that average HOXA10 mRNA levels normalized to GAPDH in treated ESCs were significantly elevated compared to nontreated ESCs (control; <italic>P</italic> &lt; .01). (C) Western blot of HOXA10 protein in 6 samples of treated ESCs and 6 samples of nontreated ESCs. β-Actin protein was assayed as an internal control. (D) Quantitative analysis of pooled data showed that average HOXA10 protein normalized to β-actin in treated ESCs was significantly increased compared to nontreated ESCs (control; <italic>P</italic> &lt; .05).</p>
</caption>
<graphic xlink:href="10.1177_1933719112451146-fig3.tif"/>
</fig>
<table-wrap id="table1-1933719112451146" position="float">
<label>Table 1.</label>
<caption>
<p>The Viable ESCs Numbers After Treatment With Various Concentrations of 5-Azacytidine<sup>a</sup></p>
</caption>
<graphic alternate-form-of="table1-1933719112451146" xlink:href="10.1177_1933719112451146-table1.tif"/>
<table>
<thead>
<tr>
<th>Concentrations of 5-Azacytidine (μg/mL)</th>
<th>0.5</th>
<th>1</th>
<th>2</th>
<th>4</th>
<th>6</th>
<th>8</th>
</tr>
</thead>
<tbody>
<tr>
<td>The cell numbers</td>
<td>9.1 × 10<sup>4</sup>
</td>
<td>6.7 × 10<sup>4</sup>
</td>
<td>5.6 × 10<sup>4</sup>
</td>
<td>4.0 × 10<sup>3</sup>
</td>
<td>1.2 × 10<sup>3</sup>
</td>
<td>2.0 × 10<sup>2</sup>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1933719112451146">
<p>Abbreviation: ESCs, endometrium stromal cells.</p>
</fn>
<fn id="table-fn2-1933719112451146">
<p>
<sup>a</sup> ESCs viability was determined by the trypan blue exclusion method after treatment without or with various concentrations (0.5, 1, 2, 4, 6, and 8 μg/mL) of 5-azacytidine.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec id="section16-1933719112451146">
<title>Discussion</title>
<p>Primary heritable genetic information is dictated by the DNA sequence that is packed into chromatin. The basic repeating unit of chromatin is a nucleosome consisting of 146 to 147 base pairs of DNA wrapped around a histone octamer. Both DNA and histone proteins can undergo various postsynthetic modifications. These modifications, along with histone variants and nucleosome remodelers, have the ability to strongly influence chromatin structure and transcriptional regulation without changing the underlying DNA sequence, a process called epigenetic regulation. Epigenetic regulation can be roughly separated into 3 interrelated layers: nucleosome positioning, histone modifications, and DNA methylation.<sup><xref ref-type="bibr" rid="bibr22-1933719112451146">22</xref><xref ref-type="bibr" rid="bibr23-1933719112451146"/>–<xref ref-type="bibr" rid="bibr24-1933719112451146">24</xref></sup> DNA methylation is probably the most extensively studied epigenetic mark and plays an important role in genomic imprinting. In mammalian cells, a methyl group is covalently added to cytosine in the context of CpG (cytosine-phosphate-guanine) dinucleotides in somatic cells.<sup><xref ref-type="bibr" rid="bibr22-1933719112451146">22</xref></sup> Nearly 60% of mammalian gene promoters are located in CpG islands.<sup><xref ref-type="bibr" rid="bibr25-1933719112451146">25</xref></sup> DNA methylation of these CpG-rich promoters silences gene expression by changing the accessibility of DNA to transcription factors or by recruiting additional silencing-associated proteins.<sup><xref ref-type="bibr" rid="bibr26-1933719112451146">26</xref></sup></p>
<p>A previous study<sup><xref ref-type="bibr" rid="bibr27-1933719112451146">27</xref></sup> tested the hypothesis of alteration in DNA methylation in the endometriotic endometrium. DNA methylation was confirmed as a mechanism responsible for severely increased ESR2 mRNA levels. The methylation of a CpG island in the ESR2 promoter region is a primary mechanism responsible for differential expression of ESR2 in endometriosis and the endometrium. A classical CpG island occurs in the promoter region of the SF-1 gene, and promoter methylation is a major mechanism of SF-1 silencing in NE cells and aberrant expression in endometriotic cells.<sup><xref ref-type="bibr" rid="bibr20-1933719112451146">20</xref></sup> Among the factors involved in infertility, endometrial receptivity decrease is responsible for approximately two thirds of implantation failures.<sup><xref ref-type="bibr" rid="bibr28-1933719112451146">28</xref></sup> In patients with endometriosis, markers for endometrial receptivity are altered including HOXA10, HOXA11, SOD, glycodelin, OPN, integrin β3, and IGFBP-1.<sup><xref ref-type="bibr" rid="bibr29-1933719112451146">29</xref><xref ref-type="bibr" rid="bibr30-1933719112451146"/>–<xref ref-type="bibr" rid="bibr31-1933719112451146">31</xref></sup> HOXA10 expression is regulated by estrogen and progesterone in the endometrium and its expression increases in the mid-secretory phase of the menstrual cycle.<sup><xref ref-type="bibr" rid="bibr32-1933719112451146">32</xref></sup> This was also confirmed in our study. We not only confirmed that HOXA10 mRNA and protein expression at the secretory phase was significantly higher than at the proliferative phase in NE, but also found that both HOXA10 mRNA and protein levels were significantly lower in the eutopic endometriotic endometrium of fertile women. This finding was consistent with a previous study showing significant downregulation of HOXA10 in infertile patients with endometriosis.<sup><xref ref-type="bibr" rid="bibr33-1933719112451146">33</xref></sup></p>
<p>Recent studies demonstrate that hypermethylation in the CpG islands of the promoter of HOXA10 causes a decrease in its expression. Epigenetic alteration might be responsible for this aberration by elevating the DNA methylation in the CpG clusters of the HOXA10 gene promoter.<sup><xref ref-type="bibr" rid="bibr34-1933719112451146">34</xref>,<xref ref-type="bibr" rid="bibr35-1933719112451146">35</xref></sup> Block et al<sup><xref ref-type="bibr" rid="bibr36-1933719112451146">36</xref></sup> found that increased levels of DNA methylation in both the promoter and the intron of HOXA10 were observed after in utero exposure to diethylstilbestrol, in which another estrogenic endocrine disrupting compounds. However, Bromer et al’s<sup><xref ref-type="bibr" rid="bibr37-1933719112451146">37</xref></sup> study suggests that hypomethylation of the HOXA10 gene is a mechanism responsible for bisphenol A related altered developmental programming of the HOXA10 gene. Hastings et al asserted that c-fos overexpression induces abnormal methylation of genes such as ESR, PR, and HOXA10 in the early stage of endometriosis.<sup><xref ref-type="bibr" rid="bibr38-1933719112451146">38</xref></sup> Wu et al found an aberrant methylation status in 3 fragments in 2 regions of the HOXA10 promoter in the eutopic endometrium of patients with endometriosis compared to the NE from patients without endometriosis.<sup><xref ref-type="bibr" rid="bibr17-1933719112451146">17</xref></sup> One mechanism for the diminished expression of HOXA10 in endometriosis is hypermethylation of the gene.</p>
<p>Increasing knowledge of the action mechanism of 5-ac indicates that lower doses of 5-ac could act as DNMT inhibitors with minimal effect on DNA synthesis. Two main mechanisms of antineoplastic action have been identified for 5-ac, namely the capacity to incorporate directly into RNA with subsequent disruption of RNA metabolism, and to inhibit DNA methylation. The second mechanism of action, the inhibition of DNA methylation, is by trapping DNMTs. In general, DNA methylation refers to the addition of a methyl group to the cytosine residue of a CpG site. The degree of methylation of CpG islands plays a role in the control of gene transcription. Usually, fully methylated sites are associated with suppression of gene expression, while hypomethylated or unmethylated CpG islands are linked to active transcription. Forming a tight-binding complex, 5-ac irreversibly binds to methyltransferase. It inhibits the enzyme in its progression along the DNA duplex and functionally depletes it from the cell. Consequently, unmethylated DNA can lead to the transcription of previously quiescent genes.<sup><xref ref-type="bibr" rid="bibr18-1933719112451146">18</xref>,<xref ref-type="bibr" rid="bibr39-1933719112451146">39</xref></sup></p>
<p>In this study, we used the DNMT inhibitor 5-ac to modulate the methylation status of the HOXA10 promoter in primary ESCs from the eutopic endometrium of endometriosis patients. We found that HOXA10 mRNA and protein expression were markedly upregulated in the EEES after treatment with 5-ac, indirectly confirming that HOXA10 hypermethylation exists in the eutopic endometrium of endometriosis patients. To our knowledge, this is the first evidence that epigenetic modification enhances HOXA10 expression. This observation suggested that a disorder of a methylation-dependent suppression mechanism could cause downregulation of HOXA10 in EEES.</p>
<p>In conclusion, this study demonstrated that HOXA10 mRNA and protein expression levels in EEE were significantly lower in fertile patients affected with endometriosis. However, demethylation of cultured ESCs by 5-ac treatment significantly increased HOXA10 mRNA and protein expression for EEES. This study is a first attempt to determine whether epigenetic modification by 5-ac enhanced HOXA10 expression. Future studies are necessary to confirm the findings in larger samples and to investigate the promoter in vivo before and after 5-ac treatment.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>Xiaojun Tang, Biomics Biotechnologies Co Ltd engineer, is thanked for providing technical support for the experimental process.</p>
</ack>
<fn-group>
<fn fn-type="other" id="fn1a-1933719112451146"><label>Authors' Note</label>
<p>Hong Lu and Xiaoqing Yang contributed equally to this work.</p></fn>
<fn fn-type="conflict" id="fn1-1933719112451146"><label>Declaration of Conflicting Interests</label>
<p>The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn2-1933719112451146"><label>Funding</label>
<p>The authors received no financial support for the research, authorship, and/or publication of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1933719112451146">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bulun</surname>
<given-names>SE</given-names>
</name>
</person-group>. <article-title>Endometriosis</article-title>. <source>N Engl J Med</source>. <year>2009</year>;<volume>360</volume>(<issue>3</issue>):<fpage>268</fpage>–<lpage>279</lpage>.</citation>
</ref>
<ref id="bibr2-1933719112451146">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guzick</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Silliman</surname>
<given-names>NP</given-names>
</name>
<name>
<surname>Adamson</surname>
<given-names>GD</given-names>
</name>
<etal/>
</person-group> <article-title>Prediction of pregnancy in infertile women based on the American Society for Reproductive Medicine's revised classification of endometriosis</article-title>. <source>Fertil Steril</source>. <year>1997</year>;<volume>67</volume>(<issue>5</issue>):<fpage>822</fpage>–<lpage>829</lpage>.</citation>
</ref>
<ref id="bibr3-1933719112451146">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buyalos</surname>
<given-names>RP</given-names>
</name>
<name>
<surname>Agarwal</surname>
<given-names>SK</given-names>
</name>
</person-group>. <article-title>Endometriosis-associated infertility</article-title>. <source>Curr Opin Obstet Gynecol</source>. <year>2000</year>;<volume>12</volume>(<issue>5</issue>):<fpage>377</fpage>–<lpage>381</lpage>.</citation>
</ref>
<ref id="bibr4-1933719112451146">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bazer</surname>
<given-names>FW</given-names>
</name>
<name>
<surname>Spencer</surname>
<given-names>TE</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>GA</given-names>
</name>
</person-group>. <article-title>Interferons and uterine receptivity</article-title>. <source>Semin Reprod Med</source>. <year>2009</year>;<volume>27</volume>(<issue>1</issue>):<fpage>90</fpage>–<lpage>102</lpage>.</citation>
</ref>
<ref id="bibr5-1933719112451146">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>HS</given-names>
</name>
</person-group>. <article-title>Xenoestrogen exposure imprints expression of genes (HOXa10) required for normal uterine developmental</article-title>. <source>FASEB J</source>. <year>2007</year>;<volume>21</volume>(<issue>1</issue>):<fpage>239</fpage>–<lpage>246</lpage>.</citation>
</ref>
<ref id="bibr6-1933719112451146">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Das</surname>
<given-names>SK</given-names>
</name>
</person-group>. <article-title>Regional development of uterine decidualization: molecular signaling by Hoxa-10</article-title>. <source>Mol Reprod Dev</source>. <year>2010</year>;<volume>77</volume>(<issue>5</issue>):<fpage>387</fpage>–<lpage>396</lpage>.</citation>
</ref>
<ref id="bibr7-1933719112451146">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kulp</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>HS</given-names>
</name>
</person-group>. <article-title>Aberrant HOXa10 methylation in patients with uterine myomas, endometriosis or uterine septum: a possible contribution to poor reproductive outcomes</article-title>. <source>Reprod Sci</source>. <year>2011</year>;<volume>18</volume>(<issue>3</issue>):<fpage>228A</fpage>–<lpage>229A</lpage>.</citation>
</ref>
<ref id="bibr8-1933719112451146">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benson</surname>
<given-names>GV</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Paria</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Satokata</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Dey</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Maas</surname>
<given-names>RL</given-names>
</name>
</person-group>. <article-title>Mechanisms of reduced fertility in Hoxa-10 mutant mice: uterine homeosis and loss of maternal Hoxa-10 expression</article-title>. <source>Development</source>. <year>1996</year>;<volume>122</volume>(<issue>9</issue>):<fpage>2687</fpage>–<lpage>2696</lpage>.</citation>
</ref>
<ref id="bibr9-1933719112451146">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bromleigh</surname>
<given-names>VC</given-names>
</name>
</person-group>, <article-title>Freedman LP. p21 is a transcriptional target of HOXA10 in differentiating myelomonocytic cells</article-title>. <source>Genes Dev</source>. <year>2000</year>;<volume>14</volume>(<issue>20</issue>):<fpage>2581</fpage>–<lpage>2586</lpage>.</citation>
</ref>
<ref id="bibr10-1933719112451146">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferrell</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Dorsam</surname>
<given-names>ST</given-names>
</name>
<name>
<surname>Ohta</surname>
<given-names>H</given-names>
</name>
<etal/>
</person-group> <article-title>Activation of stem-cell specific genes by HOXA9 and HOXA10 homeodomain proteins in CD34+ human cord blood cells</article-title>. <source>Stem Cells</source>. <year>2005</year>;<volume>23</volume>(<issue>5</issue>):<fpage>644</fpage>–<lpage>655</lpage>.</citation>
</ref>
<ref id="bibr11-1933719112451146">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Daftary</surname>
<given-names>GS</given-names>
</name>
<name>
<surname>Troy</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Bagot</surname>
<given-names>CN</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>HS</given-names>
</name>
</person-group>. <article-title>Direct regulation of beta3-integrin subunit gene expression by HOXA10 in endometrial cells</article-title>. <source>Mol Endocrinol</source>. <year>2002</year>;<volume>16</volume>(<issue>3</issue>):<fpage>571</fpage>–<lpage>579</lpage>.</citation>
</ref>
<ref id="bibr12-1933719112451146">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Daikoku</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Tranguch</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Friedman</surname>
<given-names>DB</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>DF</given-names>
</name>
<name>
<surname>Dey</surname>
<given-names>SK</given-names>
</name>
</person-group>. <article-title>Proteomic analysis identifies immunophilin FK506 binding protein 4 (FKBP52) as a downstream target of Hoxa10 in the periimplantation mouse uterus</article-title>. <source>Mol Endocrinol</source>. <year>2005</year>;<volume>19</volume>(<issue>3</issue>):<fpage>683</fpage>–<lpage>697</lpage>.</citation>
</ref>
<ref id="bibr13-1933719112451146">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Z</given-names>
</name>
<etal/>
</person-group> <article-title>Altered expression of HOXA10 in endometriosis: potential role in decidualization</article-title>. <source>Mol Hum Reprod</source>. <year>2007</year>;<volume>13</volume>(<issue>5</issue>):<fpage>323</fpage>–<lpage>332</lpage>.</citation>
</ref>
<ref id="bibr14-1933719112451146">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Troy</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Daftary</surname>
<given-names>GS</given-names>
</name>
<name>
<surname>Bagot</surname>
<given-names>CN</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>HS</given-names>
</name>
</person-group>. <article-title>Transcriptional repression of peri-implantation EMX2 expression in mammalian reproduction by HOXA10</article-title>. <source>Mol Cell Biol</source>. <year>2003</year>;<volume>23</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>13</lpage>.</citation>
</ref>
<ref id="bibr15-1933719112451146">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taylor</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Bagot</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kardana</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Olive</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Arici</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>HOX gene expression is altered in the endometrium of women with endometriosis</article-title>. <source>Hum Reprod</source>. <year>1999</year>;<volume>14</volume>(<issue>5</issue>):<fpage>1328</fpage>–<lpage>1331</lpage>.</citation>
</ref>
<ref id="bibr16-1933719112451146">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cermik</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Selam</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>HS</given-names>
</name>
</person-group>. <article-title>Regulation of HOXA-10 expression by testosterone in vitro and in the endometrium of patients with polycystic ovary syndrome</article-title>. <source>J Clin Endocrinol Metab</source>. <year>2003</year>;<volume>88</volume>(<issue>1</issue>):<fpage>238</fpage>–<lpage>243</lpage>.</citation>
</ref>
<ref id="bibr17-1933719112451146">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Halverson</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Basir</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Strawn</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>SW</given-names>
</name>
</person-group>. <article-title>Aberrant methylation at HOXA10 may be responsible for its aberrant expression in the endometrium of patients with endometriosis</article-title>. <source>Am J Obstet Gynecol</source>. <year>2005</year>;<volume>193</volume>(<issue>2</issue>):<fpage>371</fpage>–<lpage>380</lpage>.</citation>
</ref>
<ref id="bibr18-1933719112451146">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muller</surname>
<given-names>A</given-names>
</name>
</person-group>, <article-title>Florek M. 5-Azacytidine/Azacitidine</article-title>. <source>Recent Results Cancer Res</source>. <year>2010</year>;<volume>184</volume>:<fpage>159</fpage>–<lpage>170</lpage>.</citation>
</ref>
<ref id="bibr19-1933719112451146">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jichan</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Xishi</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>SW</given-names>
</name>
</person-group>. <article-title>Promoter hypermethylation of progesterone receptor isoform B (PR-B) in adenomyosis and its rectification by a histone deacetylase inhibitor and a demethylation agent</article-title>. <source>Reprod Sci</source>. <year>2010</year>;<volume>17</volume>(<issue>11</issue>):<fpage>995</fpage>–<lpage>1005</lpage>.</citation>
</ref>
<ref id="bibr20-1933719112451146">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xue</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group> <article-title>Transcriptional activation of steroidogenic factor-1 by hypomethylation of the 5′ CpG island in endometriosis</article-title>. <source>J Clin Endocrinol Metab</source>. <year>2007</year>;<volume>92</volume>(<issue>8</issue>):<fpage>3261</fpage>–<lpage>3267</lpage>.</citation>
</ref>
<ref id="bibr21-1933719112451146">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>B</given-names>
</name>
</person-group>. <article-title>Mesenchymal stem cells derived from Wharton jelly of the human umbilical cord ameliorate damage to human endometrial stromal cells</article-title>. <source>Fertil Steril</source>. <year>2011</year>;<volume>96</volume>(<issue>4</issue>):<fpage>1029</fpage>–<lpage>1036</lpage>.</citation>
</ref>
<ref id="bibr22-1933719112451146">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jones</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Baylin</surname>
<given-names>SB</given-names>
</name>
</person-group>. <article-title>The epigenomics of cancer</article-title>. <source>Cell</source>. <year>2007</year>;<volume>128</volume>(<issue>4</issue>):<fpage>683</fpage>–<lpage>692</lpage>.</citation>
</ref>
<ref id="bibr23-1933719112451146">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lister</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Pelizzola</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Dowen</surname>
<given-names>RH</given-names>
</name>
<etal/>
</person-group> <article-title>Human DNA methylomes at base resolution show widespread epigenomic differences</article-title>. <source>Nature</source>. <year>2009</year>;<volume>462</volume>(<issue>7271</issue>):<fpage>315</fpage>–<lpage>322</lpage>.</citation>
</ref>
<ref id="bibr24-1933719112451146">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Lay</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>PA</given-names>
</name>
</person-group>. <article-title>Targeting DNA methylation for epigenetic therapy</article-title>. <source>Trends Pharmacol Sci</source>. <year>2010</year>;<volume>31</volume>(<issue>11</issue>):<fpage>536</fpage>–<lpage>546</lpage>.</citation>
</ref>
<ref id="bibr25-1933719112451146">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Leung</surname>
<given-names>FC</given-names>
</name>
</person-group>. <article-title>An evaluation of new criteria for CpG islands in the human genome as gene markers</article-title>. <source>Bioinformatics</source>. <year>2004</year>;<volume>20</volume>(<issue>7</issue>):<fpage>1170</fpage>–<lpage>1177</lpage>.</citation>
</ref>
<ref id="bibr26-1933719112451146">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jones</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>G</given-names>
</name>
</person-group>. <article-title>Rethinking how DNA methylation patterns are maintained</article-title>. <source>Nat Rev Genet</source>. <year>2009</year>;<volume>10</volume>(<issue>11</issue>):<fpage>805</fpage>–<lpage>811</lpage>.</citation>
</ref>
<ref id="bibr27-1933719112451146">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xue</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>YH</given-names>
</name>
<etal/>
</person-group> <article-title>Promoter methylation regulates estrogen receptor 2 in human endometrium and endometriosis</article-title>. <source>Biol Reprod</source>. <year>2007</year>;<volume>77</volume>(<issue>4</issue>):<fpage>681</fpage>–<lpage>687</lpage>.</citation>
</ref>
<ref id="bibr28-1933719112451146">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cakmak</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>HS</given-names>
</name>
</person-group>. <article-title>Implantation failure: molecular mechanisms and clinical treatment</article-title>. <source>Hum Reprod Update</source>. <year>2011</year>;<volume>17</volume>(<issue>2</issue>):<fpage>242</fpage>–<lpage>253</lpage>.</citation>
</ref>
<ref id="bibr29-1933719112451146">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cakmak</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>HS</given-names>
</name>
</person-group>. <article-title>Molecular mechanisms of treatment resistance in endometriosis: the role of progesterone-hox gene interactions</article-title>. <source>Semin Reprod Med</source>. <year>2010</year>;<volume>28</volume>(<issue>1</issue>):<fpage>69</fpage>–<lpage>74</lpage>.</citation>
</ref>
<ref id="bibr30-1933719112451146">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wei</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>St Clair</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Stratton</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Nieman</surname>
<given-names>LK</given-names>
</name>
</person-group>. <article-title>Reduced expression of biomarkers associated with the implantation window in women with endometriosis</article-title>. <source>Fertil Steril</source>. <year>2009</year>;<volume>91</volume>(<issue>5</issue>):<fpage>1686</fpage>–<lpage>1691</lpage>.</citation>
</ref>
<ref id="bibr31-1933719112451146">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lessey</surname>
<given-names>BA</given-names>
</name>
</person-group>. <article-title>Implantation defects in infertile women with endometriosis</article-title>. <source>Ann N Y Acad Sci</source>. <year>2002</year>;<volume>955</volume>:<fpage>265</fpage>–<lpage>280</lpage>; <comment>discussion 293-265, 396-406</comment>.</citation>
</ref>
<ref id="bibr32-1933719112451146">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taylor</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Arici</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Olive</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Igarashi</surname>
<given-names>P</given-names>
</name>
</person-group>. <article-title>HOXA10 is expressed in response to sex steroids at the time of implantation in the human endometrium</article-title>. <source>J Clin Invest</source>. <year>1998</year>;<volume>101</volume>(<issue>7</issue>):<fpage>1379</fpage>–<lpage>1384</lpage>.</citation>
</ref>
<ref id="bibr33-1933719112451146">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matsuzaki</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Canis</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Darcha</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Pouly</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Mage</surname>
<given-names>G</given-names>
</name>
</person-group>. <article-title>HOXA-10 expression in the mid-secretory endometrium of infertile patients with either endometriosis, uterine fibromas or unexplained infertility</article-title>. <source>Hum Reprod</source>. <year>2009</year>;<volume>24</volume>(<issue>12</issue>):<fpage>3180</fpage>–<lpage>3187</lpage>.</citation>
</ref>
<ref id="bibr34-1933719112451146">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>HS</given-names>
</name>
</person-group>. <article-title>Experimental murine endometriosis induces DNA methylation and altered gene expression in eutopic endometrium</article-title>. <source>Biol Reprod</source>. <year>2009</year>;<volume>80</volume>(<issue>1</issue>):<fpage>79</fpage>–<lpage>85</lpage>.</citation>
</ref>
<ref id="bibr35-1933719112451146">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Kwon</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>Y</given-names>
</name>
<etal/>
</person-group> <article-title>Distinct patterns of promoter CpG island methylation of breast cancer subtypes are associated with stem cell phenotypes</article-title>. <source>Mod Pathol</source>. <year>2012</year>; <volume>25</volume>(<issue>2</issue>):<fpage>185</fpage>–<lpage>196</lpage>.</citation>
</ref>
<ref id="bibr36-1933719112451146">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Block</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kardana</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Igarashi</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>HS</given-names>
</name>
</person-group>. <article-title>In utero diethylstilbestrol (DES), exposure alters hox gene expression in the developing müllerian system</article-title>. <source>FASEB J</source>. <year>2000</year>;<volume>14</volume>(<issue>9</issue>):<fpage>1101</fpage>–<lpage>1108</lpage>.</citation>
</ref>
<ref id="bibr37-1933719112451146">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bromer</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Doherty</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>HS</given-names>
</name>
</person-group>. <article-title>Bisphenol A (BPA) exposure in utero leads to epigenetic alterations in the development programming of uterine estrogen response</article-title>. <source>FASEB J</source>. <year>2010</year>;<volume>24</volume>(<issue>7</issue>):<fpage>2273</fpage>–<lpage>2280</lpage>.</citation>
</ref>
<ref id="bibr38-1933719112451146">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hastings</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Fazleabas</surname>
<given-names>AT</given-names>
</name>
</person-group>. <article-title>A baboon model for endometriosis: implications for fertility</article-title>. <source>Reprod Biol Endocrinol</source>. <year>2006</year>;(<issue>4 suppl 1</issue>):<fpage>S7</fpage>.</citation>
</ref>
<ref id="bibr39-1933719112451146">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taylor</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>PA</given-names>
</name>
</person-group>. <article-title>Mechanism of action of eukaryotic DNA methyltransferase. Use of 5-azacytosine-containing DNA</article-title>. <source>J Mol Biol</source>. <year>1982</year>;<volume>162</volume>(<issue>3</issue>):<fpage>679</fpage>–<lpage>692</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>